• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MDS 临床帕金森病诊断标准的验证。

Validation of the MDS clinical diagnostic criteria for Parkinson's disease.

机构信息

Department of Neurology, Montreal General Hospital, Montreal, Quebec, Canada.

Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

出版信息

Mov Disord. 2018 Oct;33(10):1601-1608. doi: 10.1002/mds.27362. Epub 2018 Aug 25.

DOI:10.1002/mds.27362
PMID:30145797
Abstract

BACKGROUND

In 2015, the International Parkinson and Movement Disorder Society published clinical diagnostic criteria for Parkinson's disease. These criteria aimed to codify/reproduce the expert clinical diagnostic process and to help standardize diagnosis in research and clinical settings. Their accuracy compared with expert clinical diagnosis has not been tested. The objectives of this study were to validate the International Parkinson and Movement Disorder Society diagnostic criteria against a gold standard of expert clinical diagnosis, and to compare concordance/accuracy of the International Parkinson and Movement Disorder Society criteria to 1988 United Kingdom Brain Bank criteria.

METHODS

From 8 centers, we recruited 626 parkinsonism patients (434 PD, 192 non-PD). An expert neurologist diagnosed each patient as having PD or non-PD, regardless of International Parkinson and Movement Disorder Society criteria (gold standard, clinical diagnosis). Then a second neurologist evaluated the presence/absence of each individual item from the International Parkinson and Movement Disorder Society criteria. The overall accuracy/concordance rate, sensitivity, and specificity of the International Parkinson and Movement Disorder Society criteria compared with the expert gold standard were calculated.

RESULTS

Of 434 patients diagnosed with PD, 94.5% met the International Parkinson and Movement Disorder Society criteria for probable PD (5.5% false-negative rate). Of 192 non-PD patients, 88.5% were identified as non-PD by the criteria (11.5% false-positive rate). The overall accuracy for probable PD was 92.6%. In addition, 59.3% of PD patients and only 1.6% of non-PD patients met the International Parkinson and Movement Disorder Society criteria for clinically established PD. In comparison, United Kingdom Brain Bank criteria had lower sensitivity (89.2%, P = 0.008), specificity (79.2%, P = 0.018), and overall accuracy (86.4%, P < 0.001). Diagnostic accuracy did not differ according to age or sex. Specificity improved as disease duration increased.

CONCLUSIONS

The International Parkinson and Movement Disorder Society criteria demonstrated high sensitivity and specificity compared with the gold standard, expert diagnosis, with sensitivity and specificity both higher than United Kingdom Brain Bank criteria. © 2018 International Parkinson and Movement Disorder Society.

摘要

背景

2015 年,国际帕金森病和运动障碍协会发布了帕金森病的临床诊断标准。这些标准旨在编纂/再现专家临床诊断过程,并帮助在研究和临床环境中标准化诊断。它们与专家临床诊断的准确性尚未得到验证。本研究的目的是验证国际帕金森病和运动障碍协会的诊断标准是否符合专家临床诊断的金标准,并比较国际帕金森病和运动障碍协会标准与 1988 年英国脑库标准的一致性/准确性。

方法

我们从 8 个中心招募了 626 名帕金森病患者(434 名 PD,192 名非 PD)。一位专家神经病学家根据国际帕金森病和运动障碍协会标准(金标准,临床诊断)对每位患者进行 PD 或非 PD 的诊断。然后,第二位神经病学家评估了国际帕金森病和运动障碍协会标准中每个项目的存在/缺失情况。计算了国际帕金森病和运动障碍协会标准与专家金标准相比的总体准确性/一致性率、敏感性和特异性。

结果

在 434 名被诊断为 PD 的患者中,94.5%符合国际帕金森病和运动障碍协会标准的可能 PD(5.5%的假阴性率)。在 192 名非 PD 患者中,88.5%的患者通过该标准被诊断为非 PD(11.5%的假阳性率)。可能 PD 的总体准确性为 92.6%。此外,59.3%的 PD 患者和仅 1.6%的非 PD 患者符合国际帕金森病和运动障碍协会标准的临床确诊 PD。相比之下,英国脑库标准的敏感性较低(89.2%,P=0.008),特异性较低(79.2%,P=0.018),总体准确性较低(86.4%,P<0.001)。诊断准确性不因年龄或性别而异。随着疾病持续时间的增加,特异性提高。

结论

与金标准(专家诊断)相比,国际帕金森病和运动障碍协会标准具有较高的敏感性和特异性,敏感性和特异性均高于英国脑库标准。© 2018 国际帕金森病和运动障碍协会。

相似文献

1
Validation of the MDS clinical diagnostic criteria for Parkinson's disease.MDS 临床帕金森病诊断标准的验证。
Mov Disord. 2018 Oct;33(10):1601-1608. doi: 10.1002/mds.27362. Epub 2018 Aug 25.
2
Movement disorder society criteria for clinically established early Parkinson's disease.运动障碍学会制定的临床明确的早期帕金森病标准。
Mov Disord. 2018 Oct;33(10):1643-1646. doi: 10.1002/mds.27431. Epub 2018 Aug 25.
3
Clinical Diagnostic Accuracy of Parkinson's Disease: Where Do We Stand?帕金森病的临床诊断准确性:我们处于何种水平?
Mov Disord. 2023 Apr;38(4):558-566. doi: 10.1002/mds.29317. Epub 2023 Jan 5.
4
Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases.新的运动障碍学会帕金森病临床诊断标准在近期发病病例的大型队列研究中的回顾性应用效用。
Parkinsonism Relat Disord. 2017 Jul;40:40-46. doi: 10.1016/j.parkreldis.2017.04.006. Epub 2017 Apr 12.
5
MDS clinical diagnostic criteria for Parkinson's disease.帕金森病的MDS临床诊断标准。
Mov Disord. 2015 Oct;30(12):1591-601. doi: 10.1002/mds.26424.
6
Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts.运动障碍协会帕金森病前驱期研究标准在2个独立前瞻性队列中的应用。
Mov Disord. 2017 Jul;32(7):1025-1034. doi: 10.1002/mds.27035. Epub 2017 May 16.
7
Validation of the MDS research criteria for prodromal Parkinson's disease: Longitudinal assessment in a REM sleep behavior disorder (RBD) cohort.验证前驱期帕金森病的 MDS 研究标准:在 REM 睡眠行为障碍 (RBD) 队列中的纵向评估。
Mov Disord. 2017 Jun;32(6):865-873. doi: 10.1002/mds.26989. Epub 2017 Apr 21.
8
MDS clinical diagnostic criteria for Parkinson's disease in China.中国帕金森病的MDS临床诊断标准。
J Neurol. 2017 Mar;264(3):476-481. doi: 10.1007/s00415-016-8370-2. Epub 2016 Dec 26.
9
Performance of the Movement Disorders Society criteria for prodromal Parkinson's disease: A population-based 10-year study.运动障碍学会前驱帕金森病标准的表现:一项基于人群的 10 年研究。
Mov Disord. 2018 Mar;33(3):405-413. doi: 10.1002/mds.27281. Epub 2018 Feb 13.
10
[New Diagnostic Criteria for Parkinson's Disease: MDS-PD Criteria].[帕金森病的新诊断标准:MDS-PD标准]
Brain Nerve. 2018 Feb;70(2):139-146. doi: 10.11477/mf.1416200966.

引用本文的文献

1
Gut microbial production of imidazole propionate drives Parkinson's pathologies.肠道微生物产生的咪唑丙酸会引发帕金森病病理变化。
Nat Commun. 2025 Sep 5;16(1):8216. doi: 10.1038/s41467-025-63473-4.
2
Parkinson's Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation.帕金森病:弥合差距、构建生物标志物及重塑临床转化
Cells. 2025 Jul 28;14(15):1161. doi: 10.3390/cells14151161.
3
Effect of Deep Learning-Based Artificial Intelligence on Radiologists' Performance in Identifying Nigrosome 1 Abnormalities on Susceptibility Map-Weighted Imaging.
基于深度学习的人工智能对放射科医生在 susceptibility 图加权成像上识别黑质 1 异常表现的影响。
Korean J Radiol. 2025 Aug;26(8):771-781. doi: 10.3348/kjr.2025.0208.
4
Study Protocol: Investigating the Effects of Transcranial Pulse Stimulation in Parkinson's Disease.研究方案:探究经颅脉冲刺激对帕金森病的影响。
Bioengineering (Basel). 2025 Jul 17;12(7):773. doi: 10.3390/bioengineering12070773.
5
Parkinson Disease Signaling Pathways, Molecular Mechanisms, and Potential Therapeutic Strategies: A Comprehensive Review.帕金森病信号通路、分子机制及潜在治疗策略:综述
Int J Mol Sci. 2025 Jul 3;26(13):6416. doi: 10.3390/ijms26136416.
6
Enrichment of gut-derived metabolites in a Parkinson's disease subtype with REM sleep behavior disorder.快速眼动睡眠行为障碍型帕金森病亚型中肠道衍生代谢物的富集
NPJ Parkinsons Dis. 2025 Jul 1;11(1):189. doi: 10.1038/s41531-025-01040-w.
7
The combination of the F-FDG PET and susceptibility-weighted imaging for diagnosis of cerebral glucose metabolism and iron deposition in Parkinson's disease.18F-氟代脱氧葡萄糖正电子发射断层显像(F-FDG PET)与磁敏感加权成像联合用于帕金森病脑葡萄糖代谢及铁沉积的诊断
Sci Rep. 2025 Jun 6;15(1):20029. doi: 10.1038/s41598-025-02672-x.
8
Correlation of Parkinson's disease severity and F-FDG and F-FP-DTBZ PET.帕金森病严重程度与氟代脱氧葡萄糖(F-FDG)及氟代苯丙氨酸-多巴胺转运体显像剂(F-FP-DTBZ)正电子发射断层显像(PET)的相关性
Quant Imaging Med Surg. 2025 Apr 1;15(4):3036-3047. doi: 10.21037/qims-24-2047. Epub 2025 Mar 28.
9
Skin α-synuclein assays in diagnosing Parkinson's disease: a systematic review and meta-analysis.皮肤α-突触核蛋白检测在帕金森病诊断中的应用:一项系统评价和荟萃分析
J Neurol. 2025 Apr 9;272(5):326. doi: 10.1007/s00415-025-12978-5.
10
Metabolomics in Parkinson's Disease and Correlation with Disease State.帕金森病中的代谢组学及其与疾病状态的相关性
Metabolites. 2025 Mar 18;15(3):208. doi: 10.3390/metabo15030208.